Evidence map›Paper›PMID 38540694›Full record

ArticleBiomolecules2024

Neuroprotective Effects of the Nutraceutical Dehydrozingerone and Its C

Maria Dolores Setzu, Ignazia Mocci, Davide Fabbri, Paola Carta, Patrizia Muroni, Andrea Diana, Maria Antonietta Dettori, Maria Antonietta Casu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria Dolores SetzuDepartment of Biomedical Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy.
Ignazia MocciUnit of Cagliari, CNR-Institute of Translational Pharmacology, Pula, 09050 Cagliari, Italy.
Davide FabbriUnit of Sassari, CNR-Institute of Biomolecular Chemistry, 07100 Sassari, Italy.ORCID 0000-0002-3947-5164
Paola CartaUnit of Sassari, CNR-Institute of Biomolecular Chemistry, 07100 Sassari, Italy.ORCID 0000-0001-8749-6093
Patrizia MuroniDepartment of Biomedical Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy.
Andrea DianaDepartment of Biomedical Sciences, University of Cagliari, Monserrato, 09042 Cagliari, Italy.ORCID 0000-0002-7247-6994
Maria Antonietta DettoriUnit of Sassari, CNR-Institute of Biomolecular Chemistry, 07100 Sassari, Italy.ORCID 0000-0002-8776-9271
Maria Antonietta CasuUnit of Cagliari, CNR-Institute of Translational Pharmacology, Pula, 09050 Cagliari, Italy.ORCID 0000-0001-8105-6652
University of Cagliari · ITUniversity of Sassari · IT

Funding

National Research Council FOE-2021 DBA.AD005.225University of Cagliari FIR
6 · The paper itself

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons responsible for unintended or uncontrollable movements. Mutations in the leucine-rich repeat kinase 2 locus contribute to genetic forms of PD. The fruit fly

Indexed as

Motor DisordersNeuroprotective AgentsParkinson DiseasePersons with DisabilitiesStyrenesAnimalsDietary SupplementsDopaminergic NeuronsDrosophilaDrosophila melanogasterHumansMutationmethyl-3-methoxy-4-hydroxystyryl ketoneNeuroprotective AgentsStyrenesdehydrozingeroneDrosophila melanogasterhydroxylated biphenylsLRRK2natural compoundsneuroprotectionnutraceutical compoundsParkinson’s disease

Identifiers

PMID38540694
PMCPMC10968126
OpenAlexW4392166652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.